<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
         xmlns:dc="http://purl.org/dc/elements/1.1/"
         xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
         xmlns="http://purl.org/rss/1.0/">




    



<channel rdf:about="http://www.garvan.org.au/search_rss">
  <title>Garvan Institute Garvan Institute</title>
  <link>http://www.garvan.org.au</link>
  
  <description>
    
            These are the search results for the query, showing results 1 to 15.
        
  </description>
  
  
  
  
  <image rdf:resource="http://www.garvan.org.au/logo.gif"/>

  <items>
    <rdf:Seq>
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/chairmans-address-garvan-agm.html"/>
        
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/weight-loss-reduces-artery-stiffness-in-type-2-diabetes.html"/>
        
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/potential-gene-therapy-for-patients-with-rare-disease.html"/>
        
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/rotary-awards-garvan-epigeneticist.html"/>
        
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/mathematicians-solving-today2019s-problems-of-2018systems-biology2019.html"/>
        
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/potential-to-adjust-the-volume-control-on-our-immune-response.html"/>
        
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/creating-201cdeath-defying201d-insulin-producing-islets-for-transplantation.html"/>
        
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/professor-john-mattick-wins-prestigious-hugo-chen-award.html"/>
        
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/understanding-why-some-obese-people-stay-sensitive-to-insulin.html"/>
        
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/potential-for-earlier-diagnosis-of-ovarian-cancer.html"/>
        
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/fighting-illnesses-that-accompany-the-latest-anti-psychotic-drugs.html"/>
        
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/professor-john-shine-wins-peter-wills-medal.html"/>
        
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/garvan-scientist-wins-nhmrc-prize-for-201chighly-innovative201d-proposals.html"/>
        
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/deconstructing-diabetes-2013-why-one-size-does-not-fit-all.html"/>
        
        
            <rdf:li rdf:resource="http://www.garvan.org.au/news-events/news/romain-rouet-wins-2011-castle-harlan-award.html"/>
        
    </rdf:Seq>
  </items>

</channel>

    <item rdf:about="http://www.garvan.org.au/news-events/news/chairmans-address-garvan-agm.html">        <title>Chairman outlines key Health and Medical Research issues at  Garvan AGM</title>        <link>http://www.garvan.org.au/news-events/news/chairmans-address-garvan-agm.html</link>        <description>Chairman of Garvan, Mr Bill Ferris AC, welcomed The Hon Jillian Skinner (Minister for Health and Minister for Medical Research), as well as incoming Executive Director Professor John Mattick, at this year's Annual General Meeting, held on 1 May, 2012. In his address he outlined what he sees emerging as 10 key issues / questions for resolution in the two Health and Medical Research reviews that are currently taking place - one at State, the other at Federal level.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>alison</dc:creator>        <dc:rights></dc:rights>                <dc:date>2012-05-15T04:39:21Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>
    <item rdf:about="http://www.garvan.org.au/news-events/news/weight-loss-reduces-artery-stiffness-in-type-2-diabetes.html">        <title>Weight loss reduces artery stiffness in Type 2 diabetes</title>        <link>http://www.garvan.org.au/news-events/news/weight-loss-reduces-artery-stiffness-in-type-2-diabetes.html</link>        <description>A Garvan study shows that losing 6 kg reduces artery stiffness by 20% in obese people with Type 2 diabetes. Diabetes carries a six-fold greater risk of heart disease due to atherosclerosis, or hardening of the arteries. Cardiovascular disease is the commonest cause of death in people with diabetes – accounting for 68% of all deaths.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>alison</dc:creator>        <dc:rights></dc:rights>                <dc:date>2012-05-01T21:01:13Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>
    <item rdf:about="http://www.garvan.org.au/news-events/news/potential-gene-therapy-for-patients-with-rare-disease.html">        <title>Potential gene therapy for patients with rare disease</title>        <link>http://www.garvan.org.au/news-events/news/potential-gene-therapy-for-patients-with-rare-disease.html</link>        <description>Australian scientists have discovered that a biological phenomenon known as ‘somatic reversion’, when an abnormal gene spontaneously becomes normal again, explains why some patients with a rare genetic disorder live much longer than they should. The finding provides hope for future gene therapy treatments. </description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>alison</dc:creator>        <dc:rights></dc:rights>                <dc:date>2012-05-01T05:21:47Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>
    <item rdf:about="http://www.garvan.org.au/news-events/news/rotary-awards-garvan-epigeneticist.html">        <title>Rotary awards Garvan epigeneticist in 2012</title>        <link>http://www.garvan.org.au/news-events/news/rotary-awards-garvan-epigeneticist.html</link>        <description>Garvan’s Professor Susan Clark has received a Rotary Award for Vocational Excellence in recognition of her major contributions to the field of ‘epigenetics’. Epigenetics is a branch of research that seeks to understand changes that occur in the function of genes without a change in the genome sequence.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>alison</dc:creator>        <dc:rights></dc:rights>                <dc:date>2012-03-28T20:40:54Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>
    <item rdf:about="http://www.garvan.org.au/news-events/news/mathematicians-solving-today2019s-problems-of-2018systems-biology2019.html">        <title>Mathematicians solving today’s problems of ‘systems biology’</title>        <link>http://www.garvan.org.au/news-events/news/mathematicians-solving-today2019s-problems-of-2018systems-biology2019.html</link>        <description>The current challenge for systems biology, or the study of whole body processes, is how to measure the changes that take place, moment by moment, among roughly 12,000 proteins in a cell when that cell is exposed to a stimulus – such as the hormone insulin. Bioinformaticians have now created clever software that allows exactly this kind of processing.
</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>alison</dc:creator>        <dc:rights></dc:rights>                <dc:date>2012-03-21T05:38:53Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>
    <item rdf:about="http://www.garvan.org.au/news-events/news/potential-to-adjust-the-volume-control-on-our-immune-response.html">        <title>Potential to adjust the volume control on our immune response</title>        <link>http://www.garvan.org.au/news-events/news/potential-to-adjust-the-volume-control-on-our-immune-response.html</link>        <description>Garvan scientists have shown for the first time that people need a specific gene for a critical component of the immune system to function properly. By amplifying or blocking the function of this gene, they suggest, we might be better able to fight immunodeficient states, cancers and autoimmune diseases in the future.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>alison</dc:creator>        <dc:rights></dc:rights>                <dc:date>2012-03-15T07:39:26Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>
    <item rdf:about="http://www.garvan.org.au/news-events/news/creating-201cdeath-defying201d-insulin-producing-islets-for-transplantation.html">        <title>Creating “death-defying” insulin-producing islets for transplantation</title>        <link>http://www.garvan.org.au/news-events/news/creating-201cdeath-defying201d-insulin-producing-islets-for-transplantation.html</link>        <description>Garvan scientists have identified one way of making a frustratingly tricky transplant – of insulin-producing ‘islets of Langerhans’ into patients with Type 1 diabetes – more successful. Part of the Commonwealth-funded Australian Islet Transplant Consortium formed in 2006, the Garvan team has found that islets are severely handicapped from the outset. Before they ever reach their mark, they are full of inflammatory molecules, much like stressed or damaged tissue. 
</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>kironside</dc:creator>        <dc:rights></dc:rights>                <dc:date>2012-03-12T06:06:12Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>
    <item rdf:about="http://www.garvan.org.au/news-events/news/professor-john-mattick-wins-prestigious-hugo-chen-award.html">        <title>Professor John Mattick wins prestigious HUGO Chen Award</title>        <link>http://www.garvan.org.au/news-events/news/professor-john-mattick-wins-prestigious-hugo-chen-award.html</link>        <description>Professor John Mattick AO FAA FRCPA, Garvan's Executive Director, will be presented with the Chen Award 2012 for Distinguished Academic Achievement in Human Genetic and Genomic Research, by the Human Genome Organisation (HUGO) on Wednesday evening - after he has delivered the President's Oration.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>alison</dc:creator>        <dc:rights></dc:rights>                <dc:date>2012-03-14T00:14:04Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>
    <item rdf:about="http://www.garvan.org.au/news-events/news/understanding-why-some-obese-people-stay-sensitive-to-insulin.html">        <title>Understanding why some obese people stay sensitive to insulin </title>        <link>http://www.garvan.org.au/news-events/news/understanding-why-some-obese-people-stay-sensitive-to-insulin.html</link>        <description>Obesity, especially central obesity, is associated with insulin resistance, which precedes diabetes, sometimes by more than a decade. However, it’s not only a question of body weight or fat distribution, because some obese people remain insulin-sensitive, with insulin working as well in their bodies as in someone lean.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>alison</dc:creator>        <dc:rights></dc:rights>                <dc:date>2012-01-31T04:34:36Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>
    <item rdf:about="http://www.garvan.org.au/news-events/news/potential-for-earlier-diagnosis-of-ovarian-cancer.html">        <title>Potential for earlier diagnosis of ovarian cancer </title>        <link>http://www.garvan.org.au/news-events/news/potential-for-earlier-diagnosis-of-ovarian-cancer.html</link>        <description>Garvan scientists have identified biochemical changes that commonly occur in the DNA of women with ovarian cancer, which may help diagnose the cancer at an earlier stage in the future. The study used whole genome DNA profiling methods - locating six potential 'biomarkers', one of them a novel gene.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>alison</dc:creator>        <dc:rights></dc:rights>                <dc:date>2012-01-23T04:59:50Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>
    <item rdf:about="http://www.garvan.org.au/news-events/news/fighting-illnesses-that-accompany-the-latest-anti-psychotic-drugs.html">        <title>Fighting illnesses that accompany the latest anti-psychotic drugs</title>        <link>http://www.garvan.org.au/news-events/news/fighting-illnesses-that-accompany-the-latest-anti-psychotic-drugs.html</link>        <description>Anti-psychotic drugs for treating serious mental illnesses, such as bipolar disorder or schizophrenia, are effective and often life-saving but come with unwelcome side effects. They dramatically increase weight as well as the incidence of metabolic disorders such as raised blood fats and Type 2 diabetes, say Sydney-based specialists. The rapid decline in physical health is so clinically significant, and of such concern, that the specialists put together a physical health protection algorithm last year.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>alison</dc:creator>        <dc:rights></dc:rights>                <dc:date>2012-01-11T05:44:28Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>
    <item rdf:about="http://www.garvan.org.au/news-events/news/professor-john-shine-wins-peter-wills-medal.html">        <title>Professor John Shine wins Peter Wills Medal</title>        <link>http://www.garvan.org.au/news-events/news/professor-john-shine-wins-peter-wills-medal.html</link>        <description>Professor John Shine AO FAA, Executive Director of Garvan, has received the inaugural Peter Wills Medal, created by Research Australia “to recognise an outstanding contribution to building Australia’s national and international reputation in the realm of health and medical research”.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>alison</dc:creator>        <dc:rights></dc:rights>                <dc:date>2011-12-05T22:48:50Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>
    <item rdf:about="http://www.garvan.org.au/news-events/news/garvan-scientist-wins-nhmrc-prize-for-201chighly-innovative201d-proposals.html">        <title>Garvan scientist wins NHMRC prize for “highly innovative” proposals</title>        <link>http://www.garvan.org.au/news-events/news/garvan-scientist-wins-nhmrc-prize-for-201chighly-innovative201d-proposals.html</link>        <description>Garvan Neuroscientist Dr Greg Neely has just won the new National Health and Medical Research Council (NHMRC) ‘Marshall and Warren Project Grant Award’, created to recognise the “best highly innovative and potentially transformative grant” from the 2011 Project Grants funding round.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>alison</dc:creator>        <dc:rights></dc:rights>                <dc:date>2011-11-30T04:04:37Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>
    <item rdf:about="http://www.garvan.org.au/news-events/news/deconstructing-diabetes-2013-why-one-size-does-not-fit-all.html">        <title>Deconstructing diabetes – why one size does not fit all</title>        <link>http://www.garvan.org.au/news-events/news/deconstructing-diabetes-2013-why-one-size-does-not-fit-all.html</link>        <description>Professor David James, Head of the Diabetes and Obesity Program at Garvan, believes it’s time to draw attention to the many things we don’t yet know about the complex metabolic disease we call ‘Type 2 diabetes’, and to the oversimplifications that abound in discussion of future treatments.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>alison</dc:creator>        <dc:rights></dc:rights>                <dc:date>2011-11-30T03:53:14Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>
    <item rdf:about="http://www.garvan.org.au/news-events/news/romain-rouet-wins-2011-castle-harlan-award.html">        <title>Romain Rouet wins 2011 Castle Harlan Award</title>        <link>http://www.garvan.org.au/news-events/news/romain-rouet-wins-2011-castle-harlan-award.html</link>        <description>Romain Rouet has received the $10,000 USD Castle Harlan Award for being the most outstanding early career PhD student at the Garvan Institute in 2011. Castle Harlan Inc. is a US-based private equity firm that wishes to support the kind of medical research being undertaken at Garvan. 
</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>alison</dc:creator>        <dc:rights></dc:rights>                <dc:date>2011-11-09T00:29:15Z</dc:date>        <dc:type>Garvan News</dc:type>    </item>



</rdf:RDF>

